Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells
- PMID: 11290808
- DOI: 10.4049/jimmunol.166.8.5236
Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells
Abstract
The efficiency of dendritic cells (DC) as immunotherapeutic vaccines critically depends on optimal delivery of target Ags. Although DC modified by subgroup C type 5 recombinant adenoviruses (rAd5) provide encouraging results, their clinical application is hampered by the need for high viral titers to achieve sufficient gene transfer, due to the lack of the Ad5 fiber receptor. We now demonstrate that rAd5 carrying subgroup B Ad fibers are up to 100-fold more potent than classical rAd5 for gene transfer and expression in human DC, rAd5 with a type 35 fiber (rAd5F35) being the most efficient vector. This improvement relates to a greater and faster virus entry and to an increased transgene expression especially following DC maturation. Furthermore, these new vectors possess enhanced synergistic effects with other activation signals to trigger DC maturation. Consequently, rAd5F35-infected DC engineered to express the gp100 melanoma-associated Ag largely exceed rAd5-infected DC in activating gp100-specific CTL. Finally, the DC infection pattern of rAd5F35 is fully conserved when DC are in the vicinity of primary skin-derived fibroblasts, suggesting this vector as a candidate for in vivo targeting of DC. Thus, subgroup B fiber-modified rAd5 constitute a major breakthrough in the exploitation of ex vivo rAd-targeted DC as clinically relevant vaccines and may also be suitable for in vivo genetic modification of DC.
Similar articles
-
Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors.J Immunol. 2002 Nov 1;169(9):5322-31. doi: 10.4049/jimmunol.169.9.5322. J Immunol. 2002. PMID: 12391253
-
Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.Cancer Res. 2001 Nov 1;61(21):7913-9. Cancer Res. 2001. PMID: 11691812
-
Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.J Immunol. 2001 May 1;166(9):5695-703. doi: 10.4049/jimmunol.166.9.5695. J Immunol. 2001. PMID: 11313411
-
[Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors].Yakugaku Zasshi. 2001 Aug;121(8):593-600. doi: 10.1248/yakushi.121.593. Yakugaku Zasshi. 2001. PMID: 11523120 Review. Japanese.
-
Viral vectors for dendritic cell-based immunotherapy.Curr Top Microbiol Immunol. 2003;276:241-59. doi: 10.1007/978-3-662-06508-2_11. Curr Top Microbiol Immunol. 2003. PMID: 12797451 Review.
Cited by
-
A phase 1b randomized, controlled, double-blinded dosage-escalation trial to evaluate the safety, reactogenicity and immunogenicity of an adenovirus type 35 based circumsporozoite malaria vaccine in Burkinabe healthy adults 18 to 45 years of age.PLoS One. 2013 Nov 11;8(11):e78679. doi: 10.1371/journal.pone.0078679. eCollection 2013. PLoS One. 2013. PMID: 24244339 Free PMC article. Clinical Trial.
-
New approaches to the development of adenoviral dendritic cell vaccines in melanoma.Curr Opin Investig Drugs. 2010 Dec;11(12):1399-408. Curr Opin Investig Drugs. 2010. PMID: 21154122 Free PMC article. Review.
-
Multigene RNA vector based on coronavirus transcription.J Virol. 2003 Sep;77(18):9790-8. doi: 10.1128/jvi.77.18.9790-9798.2003. J Virol. 2003. PMID: 12941887 Free PMC article.
-
An Efficient Method for the Delivery of the Interleukin-2 Gene to Human Hematopoietic Cells using the Fiber-Modified Recombinant Adenovirus.Acta Naturae. 2011 Jul;3(3):100-6. Acta Naturae. 2011. PMID: 22649700 Free PMC article.
-
Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo.J Virol. 2003 Jan;77(2):1039-48. doi: 10.1128/jvi.77.2.1039-1048.2003. J Virol. 2003. PMID: 12502819 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources